Carregant...
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis
OBJECTIVE: Deferiprone is an iron chelator that has recently been used to treat patients with infratentorial superficial siderosis (iSS). It is considered to have a generally favourable safety profile but concerns have been raised due to the risk of agranulocytosis. We aimed to evaluate the safety a...
Guardat en:
| Publicat a: | J Neurol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6954889/ https://ncbi.nlm.nih.gov/pubmed/31620867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-019-09577-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|